Hamilton Lane Incorporated (HLNE) Price Target Lowered to $150 at UBS

Core Viewpoint - Hamilton Lane Incorporated (NASDAQ:HLNE) is recognized as a stock with significant growth potential by 2026, despite recent fluctuations in price targets from various analysts [1][8]. Group 1: Analyst Ratings and Price Targets - UBS has lowered its price target for Hamilton Lane to $150 from $184 while maintaining a Buy rating, indicating that the adjustment is due to broader market conditions rather than issues specific to the company [2]. - Oppenheimer raised its price target for Hamilton Lane to $230 from $220, reiterating an Outperform rating based on strong Q3 performance, despite the stock's recent retracement amid credit-related concerns in the alternatives sector [3]. Group 2: Financial Performance - Hamilton Lane reported fiscal year-to-date GAAP EPS of $4.35 and non-GAAP EPS of $4.41, with a quarterly dividend declared at $0.54, aligning with a target of $2.16 for FY2026, which represents a 10% year-over-year increase [3]. Group 3: Strategic Developments - The company has closed a partnership with Guardian, overseeing nearly $5 billion of Guardian's private equity portfolio, which is expected to generate approximately $500 million in additional annual commitments for at least a decade, enhancing fee-related earnings visibility and long-term AUM growth prospects [4]. - Hamilton Lane's expanding platform and durable client relationships support sustained earnings and dividend growth potential, positioning the company favorably in the alternative investment management sector [5].